6065 related articles for article (PubMed ID: 3023762)
1. Constitutive production of a non-interferon macrophage activating factor by HTLV-transformed T cells.
Lee JC
Lymphokine Res; 1986; 5 Suppl 1():S127-32. PubMed ID: 3023762
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Lee JC; Rebar L; Young P; Ruscetti FW; Hanna N; Poste G
J Immunol; 1986 Feb; 136(4):1322-8. PubMed ID: 3003193
[TBL] [Abstract][Full Text] [Related]
3. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
[TBL] [Abstract][Full Text] [Related]
4. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
5. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
7. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
8. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
Schreiber RD; Pace JL; Russell SW; Altman A; Katz DH
J Immunol; 1983 Aug; 131(2):826-32. PubMed ID: 6408190
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
13. Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.
Talmadge KW; Gallati H; Sinigaglia F; Walz A; Garotta G
Eur J Immunol; 1986 Dec; 16(12):1471-7. PubMed ID: 3102242
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assay of human T-cell leukemia/lymphoma virus transformation.
Graziano SL; Lehr BM; Merl SA; Ehrlich GD; Moore JL; Hallinan EJ; Hubbell C; Davey FR; Vournakis J; Poiesz BJ
Cancer Res; 1987 May; 47(9):2468-73. PubMed ID: 3032423
[TBL] [Abstract][Full Text] [Related]
15. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones.
Kelso A; Munck A
J Immunol; 1984 Aug; 133(2):784-91. PubMed ID: 6203981
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.
Kanagawa O; Chiller JM
J Immunol; 1985 Jan; 134(1):397-403. PubMed ID: 3917280
[TBL] [Abstract][Full Text] [Related]
18. Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine?
Zlotnik A; Roberts WK; Vasil A; Blumenthal E; Larosa F; Leibson HJ; Endres RO; Graham SD; White J; Hill J; Henson P; Klein JR; Bevan MJ; Marrack P; Kappler JW
J Immunol; 1983 Aug; 131(2):794-800. PubMed ID: 6223094
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hydrogen peroxide-potentiating factor, a lymphokine that increases the capacity of human monocytes and monocyte-like cell lines to produce hydrogen peroxide.
Gately CL; Wahl SM; Oppenheim JJ
J Immunol; 1983 Dec; 131(6):2853-8. PubMed ID: 6438232
[TBL] [Abstract][Full Text] [Related]
20. Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes.
Prystowsky MB; Ely JM; Beller DI; Eisenberg L; Goldman J; Goldman M; Goldwasser E; Ihle J; Quintans J; Remold H; Vogel SN; Fitch FW
J Immunol; 1982 Dec; 129(6):2337-44. PubMed ID: 6216281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
